FinancialContent is the trusted provider of stock market information to the media industry.
DepoMed, Inc. (NQ: DEPO)
12.87 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(DEPO) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 19, 2014
(Penny Stock DD, 8/27/12)
RTTNews) - DepoMed Inc. (DEPO:Quote) announced after the close Monday that Janssen Pharmaceuticals Inc. has licensed rights to Depomed's Acuform gastric retentive drug delivery...(read more)
(, 6/24/12)
On June 21, 2012, Depomed (DEPO) announced the acquisition of the product Zipsor (diclofenac potassium) Liquid Filled Capsules from privately-held Xanodyne Pharmaceuticals, Inc. Zipsor is a...(read more)
(, 4/24/12)
On April 17, 2012, Depomed (DEPO) announced it had completed a Type B “pre-NDA” meeting with the U.S. FDA regarding the results of the three phase 3 clinical trials for Serada (extended-release...(read more)
DepoMed (DEPO) Company Overview

There is no analysis for DEPO yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More